Gene · 1902
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lactic acid exposure alters lysophosphatidic acid receptor-mediated regulation of growth and motility in pancreatic cancer cells. | Mol Cell Biochem | 2026 | 42663874 | PubTator, text mining | PubMed |
| Context-dependent lysophosphatidic acid signalling in inflammation: evidence hierarchy, myeloid regulation and translational gaps. | Inflamm Res | 2026 | 42550283 | PubTator, text mining | PubMed |
| LPA/LPAR signaling drives temporomandibular disorders-like pain through regulating the expression and sensitization of PIEZO2. | Sci Adv | 2026 | 42490435 | PubTator, text mining | PubMed |
| Lysophosphatidic acid promotes lipid metabolism through AMPK signaling to support Coxsackievirus infection. | J Virol | 2026 | 42461030 | PubTator, text mining | PubMed |
| Biomarker profiles in idiopathic and progressive pulmonary fibrosis after LPA1 antagonism: exploratory analysis from a phase 2 trial of admilparant. | Respir Res | 2026 | 42458495 | PubTator, text mining | PubMed |
| Lysophosphatidic acid (LPA) receptor-mediated signaling in the tumor microenvironment: roles in cancer progression and therapeutic potential. | Adv Biol Regul | 2026 | 42456206 | PubTator, text mining | PubMed |
| M2 Macrophage-Derived ENPP2/LPA Signalling Attenuates UVB-Induced Fibroblast Photoaging via LPAR1/3. | Exp Dermatol | 2026 | 42394134 | PubTator, text mining | PubMed |
| Discovery of PIPE-791, A Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory Disorders. | J Med Chem | 2026 | 42370792 | PubTator, text mining | PubMed |
| Targeting phospholipase A2 with arachidonyl trifluoromethyl ketone modulates macrophage activation during Japanese encephalitis virus infection. | Med Microbiol Immunol | 2026 | 42189285 | PubTator, text mining | PubMed |
| A patent review of LPAR1 antagonists (2010 - present). | Expert Opin Ther Pat | 2026 | 42132000 | PubTator, text mining | PubMed |
| Beyond attenuation: a translational review of curative-intent pharmacological targets in idiopathic pulmonary fibrosis. | Front Med (Lausanne) | 2026 | 42094953 | PubTator, text mining | PubMed |
| Structural mechanisms underlying distinct binding and activities of 18:0 and 18:1 lysophosphatidic acids at LPA1 receptor. | PLoS Comput Biol | 2026 | 42030406 | PubTator, text mining | PubMed |
| Lysophosphatidic acid mediates skeletal muscle fibrosis in denervation via activation of YAP/TAZ. | JCI Insight | 2026 | 42018654 | PubTator, text mining | PubMed |
| The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma. | J Cell Mol Med | 2026 | 41958080 | PubTator, text mining | PubMed |
| Urea-based lysophosphatidic acid receptor 1 antagonists as potential migrastatics for triple-negative breast cancer. | Bioorg Chem | 2026 | 41911633 | PubTator, text mining | PubMed |
| Mixed Signals and Interspecies Variation in the Plasticity of Adult Mammal Brains. | Cells | 2026 | 41892311 | PubTator, text mining | PubMed |
| Multi-omics profiling identifies ectopic olfactory receptors as putative drivers of tumor progression and prognostic indicators in clear cell renal cell carcinoma. | Clin Exp Med | 2026 | 41863682 | PubTator, text mining | PubMed |
| Sphingosine‑1‑phosphate receptor 1 enhances olfactory receptor 51E1‑mediated inhibition of proliferation via Src/JNK signaling in prostate cancer cells. | Oncol Rep | 2026 | 41860044 | PubTator, text mining | PubMed |
| Exploiting cellular senescence in hematologic malignancies. | Transl Oncol | 2026 | 41844438 | PubTator, text mining | PubMed |
| TBXA2R activates ERMs to drive motility, invasion, and metastatic colonization of TNBC cells. | Life Sci Alliance | 2026 | 41844278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1902/papers